Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.20.4
Consolidated Balance Sheets - USD ($)
Dec. 31, 2020
Sep. 30, 2020
Current assets:    
Cash $ 879,413 $ 959,309
Inventory 1,015,740 967,993
Prepaid expenses and other current assets 197,131 215,673
Total current assets 2,092,284 2,142,975
Long-term assets:    
Property and equipment, net 4,180 4,552
Other assets 3,500 3,500
Total long-term assets 7,680 8,052
Total assets 2,099,964 2,151,027
Current liabilities:    
Accounts payable 391,151 342,050
Accrued expenses and other liabilities 294,022 266,749
Current portion of PPP Loan 57,273 37,442
Total current liabilities 742,446 646,241
Long-term liabilities:    
Long-term portion of PPP loan 119,027 138,858
Derivative liability 2,207,475 2,316,419
Total long-term liabilities 3,926,502 3,005,277
Total liabilities 4,668,948 3,651,518
Commitments and contingencies
Stockholders' deficit:    
Common stock, $0.001 par value, 800,000,000 shares authorized as of December 31, 2020 and September 30, 2020, 193,094,766 and 193,044,766 shares issued and outstanding as of December 31, 2020 and September 30, 2020, respectively 193,045 193,045
Additional paid-in capital 41,948,512 41,862,901
Accumulated deficit (44,710,541) (43,556,437)
Total stockholders' deficit (2,568,984) (1,500,491)
Total liabilities and stockholders' deficit 2,099,964 2,151,027
Series 1 convertible notes    
Long-term liabilities:    
Convertible Notes Payable, Noncurrent 550,000 $ 550,000
Series 2 convertible notes    
Long-term liabilities:    
Convertible Notes Payable, Noncurrent $ 1,050,000